West Pharmaceutical Services (WST) Operating Income (2016 - 2025)
Historic Operating Income for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $156.6 million.
- West Pharmaceutical Services' Operating Income fell 187.97% to $156.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $584.9 million, marking a year-over-year increase of 263.2%. This contributed to the annual value of $584.9 million for FY2025, which is 263.2% up from last year.
- Latest data reveals that West Pharmaceutical Services reported Operating Income of $156.6 million as of Q4 2025, which was down 187.97% from $167.6 million recorded in Q3 2025.
- West Pharmaceutical Services' Operating Income's 5-year high stood at $228.4 million during Q2 2022, with a 5-year trough of $107.0 million in Q1 2025.
- In the last 5 years, West Pharmaceutical Services' Operating Income had a median value of $164.4 million in 2024 and averaged $165.9 million.
- In the last 5 years, West Pharmaceutical Services' Operating Income surged by 10395.75% in 2021 and then plummeted by 3084.93% in 2024.
- West Pharmaceutical Services' Operating Income (Quarter) stood at $184.0 million in 2021, then fell by 29.51% to $129.7 million in 2022, then increased by 24.06% to $160.9 million in 2023, then dropped by 0.81% to $159.6 million in 2024, then fell by 1.88% to $156.6 million in 2025.
- Its last three reported values are $156.6 million in Q4 2025, $167.6 million for Q3 2025, and $153.7 million during Q2 2025.